SCHEMBL31078052

SCHEMBL31078052

O=C(Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 2/20 0.73
▸ PTPN1 P18031 4/20 0.64
▸ DEGS1 O15121 1/20 0.63
▸ NPC1 O15118 2/20 0.60
▸ RAB9A P51151 2/20 0.60
▸ TRPV1 Q8NER1 1/20 0.58
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ POLB P06746 2/20 0.57
▸ STAT3 P40763 1/20 0.57
▸ NR1H4 Q96RI1 1/20 0.57
▸ MEN1 O00255 1/20 0.56
▸ PSMD14 O00487 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ RECQL P46063 1/20 0.56
▸ CACNA1B Q00975 1/20 0.56
▸ APBA1 Q02410 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ CTDSP1 Q9GZU7 1/20 0.56
▸ SAE1 Q9UBE0 1/20 0.56
▸ UBA2 Q9UBT2 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5314168 0.91 RORC (0.77) RORCPTPN1NPC1RAB9ASMN1; SMN2
SCHEMBL31078058 0.89 RORC (0.62) RORCPTPN1NPC1RAB9ASMN1; SMN2
SCHEMBL4880524 0.84 RORC (1.00) RORCNPC1RAB9ATRPV1SMN1; SMN2
SCHEMBL5314331 0.83 RORC (0.79) RORCPTPN1NPC1RAB9ATRPV1
SCHEMBL12334379 0.82 RORC (0.77) RORCNPC1RAB9ATRPV1SMN1; SMN2
SCHEMBL12334581 0.82 RORC (0.77) RORCNPC1RAB9ATRPV1SMN1; SMN2
SCHEMBL12334365 0.82 RORC (0.77) RORCNPC1RAB9ATRPV1SMN1; SMN2
SCHEMBL5311353 0.82 RORC (0.77) RORCNPC1RAB9ATRPV1SMN1; SMN2
SCHEMBL12334375 0.82 RORC (0.77) RORCNPC1RAB9ATRPV1SMN1; SMN2
SCHEMBL31078108 0.82 RORC (0.67) RORCSMN1; SMN2POLBMLYCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240245633-A1 ROR Gamma Agonists as Enhancers of Protective Immunity UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2024-07-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240245633-A1 ROR Gamma Agonists as Enhancers of Protective Immunity RORC, RORB, RORA RORC 1/4885PTPN1 409/4885DEGS1 2823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback